Butyl Lactate: Natural Occurrence, Versatile applications and Safety Assessment

Butyl lactate, a natural flavor compound in foods and beverages, serves as a versatile solvent in various industries, with low risk in safety assessments.

Apr 1,2024  API

Crystal structure and Uses of Beryllium nitride

Beryllium nitride is a compound of beryllium and nitrogen, prepared by heating beryllium metal powder with dry nitrogen at high temperatures (1100-1500 ℃).

Mar 29,2024  Inorganic chemistry

Structure and Properties of Tantalum Pentoxide

Tantalum pentoxide is disordered, being either amorphous or polycrystalline. It has at least 2 polymorphs exist. A low temperature form, known as L- or β-Ta2O5, and the high temperature form known as

Mar 29,2024  Inorganic chemistry

Uranium(IV) oxide:Crystal structure,Application,Preparation

Uranium(IV) oxide is characterized by high melting point, good high-temperature stability, strong radiation resistance, good corrosion resistance, and good compatibility with zirconium or stainless st

Mar 29,2024  Inorganic chemistry

Ytterbium oxide nanofibers

Ytterbium Oxide (Yb2O3) is a white Powder, water-insoluble powder with a cubic crystal structure. It is used as a colorant for glasses and enamels and as a dopant for garnet crystals in lasers.

Mar 29,2024  Inorganic chemistry

Crystal Structure of Aluminum Nitride(AlN)

Aluminum nitride has recently attracted considerable attention because of its electric ability, the most critical design aspect of a piezoelectric device is its crystal quality, this article will intr

Mar 29,2024  Inorganic chemistry

What is the difference between imatinib and nilotinib?

Nilotinib, an orally bioavailable, selective Bcr-Abl tyrosine kinase inhibitor, is 30-fold more potent than imatinib in pre-clinical models, and overcomes most imatinib resistant BCR-ABL mutations.

Mar 29,2024  API

Dasatinib: Mechanism of action and Safety

Dasatinib, a tyrosine kinase inhibitor, primarily treats chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.

Mar 29,2024  API

Lemborexant: A Dual Orexin Receptor Antagonist with Favorable Safety and Pharmacokinetic Profiles

Lemborexant promotes sleep by targeting orexin receptors, with good tolerability in adults. Caution advised for respiratory issues and potential drug interactions require careful management.

Mar 29,2024  API

The Origin, Mechanism, Potential Benefits, and Disputes of YK11

YK11 was first studied in 2011 and was found to be a partial agonist of androgen receptor (AR) with genetic selectivity.

Mar 29,2024  API
Prev12345678910...Next>  Go to Page